Ukraine Ministry of Health Accepts Entolimod Dossier for Formal Review Under Regulatory Equivalence Pathway
Valion Bio announced that Ukraine's Ministry of Health accepted the Company's regulatory dossier for Entolimod.
Valion Bio
Valion Bio is a clinical-stage biodefense and infectious disease company. Recently announced that Ukraine's Ministry of Health accepted the Company's regulatory dossier for Entolimod under a regulatory equivalence pathway.
Company Info
Upcoming Milestones & Key Dates
Q3 2026
Regulatory
Ukraine MoH review completion
Clinical Development Pipeline
Entolimod
Target: TLR5 agonistEntolimod
Target: TLR5 agonistUndisclosed
Target: TBDRecent News
Leadership Team
To be confirmed
Chief Executive Officer
To be confirmed
Chief Medical Officer
To be confirmed
Chief Scientific Officer